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The effect of incorporation of a centrally positioned Ac6c-Xxx segment where Xxx =
LVal/DVal into a
host oligopeptide composed of L-amino acid residues has been investigated. Studies of four designed
octapeptides Boc-Leu-Phe-Val-Ac6c-Xxx-Leu-Phe-Val-OMe (Xxx =
DVal 1, LVal 2) Boc-Leu-Val-Val-
Ac6c-Xxx-Leu-Val-Val-OMe (Xxx =
DVal 3, LVal 4) are reported. Diagnostic nuclear Overhouse effects
characteristic of hairpin conformations are observed for Xxx = DVal peptides (1 and 3) while continuous
helical conformation characterized by sequential NiH↔ Ni+1H NOEs are favored for Xxx =
LVal peptides
(2 and 4) in methanol solutions. Temperature co-efficient of NH chemical shifts are in agreement with
distinctly different conformational preferences upon changing the configuration of the residue at position
5. Crystal structures of peptides 2 and 4 (Xxx = LVal) establish helical conformations in the solid state, in
agreement with the structures deduced from NMR data. The results support the design principle that
centrally positioned type I β-turns may be used to nucleate helices in short peptides, while type I′ β-turns
can facilitate folding into β-hairpins.
Introduction
The induction of folded structures in short peptides may be
achieved by the appropriate placement of conformationally con-
strained residues in designed sequences.1 The imposition of
restrictions on the conformational choices at specifically posi-
tioned residues permits local folding nuclei to be formed, which
can then facilitate the stabilization of short elements of regular
secondary structures. α,α-Dialkylated residues, most notably the
prototype member of this family α-aminoisobutyric acid (Aib),
have been extensively used to design peptide helices.2 D-Proline
has emerged as the residue of choice in the creation of β-hair-
pins, a consequence of the tendency of DPro-Xxx sequences to
form type I′ or type II′ β-turn conformations.1c,3 The insertion of
D-amino acids into all L-sequences can also promote folding
because of the enhanced tendency of L/D or D/L sequences to
favor β-turn conformations.4 The observation that the centrally
positioned Aib-DAla segment facilitates β-hairpin formation in
the octapeptide Boc-Leu-Phe-Val-Aib-DAla-Leu-Phe-Val-OMe,5
prompted us to investigate the role of segments containing con-
tiguous α,α-dialkylated and D-residues upon incorporation into
all L-amino acid sequences. Fig. 1 provides a comparison of
three crystallographically characterized peptide conformations.
The Aib-DXxx segment (Xxx = DAla, DPro) promotes the for-
mation of a type I′ nucleated β-hairpin structure in designed octa-
peptides.5,6 However, the Aib-DVal segment is accommodated
into a long continuous right-handed helix in a synthetic 19-
residue peptide largely composed of L-residues.7 In this example,
the DVal residue adopts negative ϕ, ψ values in the αR region of
the Ramachandran map. Several earlier studies have indeed
established that D-residues can indeed lie in the αR region of con-
formational space,8 even though the αL-region is energetically
more favorable.9 Inspection of the three structures in Fig. 1
suggests that centrally positioned segments, containing achiral
α,α-dialkylated residues and D-residues as guests in an all L-
sequences, could lead to either hairpins or helices. In order to
assess the conformational influences of these segments we have
investigated the following designed octapeptides.
Boc-Leu-Phe-Val-Ac6c-
DVal-Leu-Phe-Val-OMe (1)
Boc-Leu-Phe-Val-Ac6c-Val-Leu-Phe-Val-OMe (2)
Boc-Leu-Val-Val-Ac6c-
DVal-Leu-Val-Val-OMe (3)
Boc-Leu-Val-Val-Ac6c-Val-Leu-Val-Val-OMe (4)
Two distinct flanking L-peptide segments were chosen Leu-
Phe-Val-Xxx-Yyy-Leu-Phe-Val and Leu-Val-Val-Xxx-Yyy-Leu-
Val-Val, in order to probe the role of potential aromatic
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interactions in stabilizing β-hairpin conformations.10 The Ac6c
residue (1-aminocyclohexane-1-carboxylic acid)11 was chosen at
position 4, while LVal and DVal were placed at position 5, in
order to establish the role of residue chirality.
Results and discussion
Fig. 2 compares the aromatic proton and amide NH resonances
observed for peptides Boc-Leu-Phe-Val-Ac6c-
DVal-Leu-Phe-Val-
OMe (1) and Boc-Leu-Phe-Val-Ac6c-Val-Leu-Phe-Val-OMe (2).
Clearly distinct distributions of backbone NH chemical shifts are
observed for the two peptides. Importantly, the observed upfield
shifts of a pair of aromatic protons (Phe(7) CδH) in peptide 1
(DVal(5)) is characteristic of β-hairpin structures, in which Phe
(2) and Phe(7) occur in close proximity at a non-hydrogen
bonding site.10 Amide NH resonances of the peptides in which
the aromatic residues have been replaced, 3 and 4, also shown
striking differences with a much larger dispersion in the case of
the DVal peptide 3. These initial observed differences point to
significant change in the conformational propensities of the pep-
tides upon changing the configuration at residue 5. Sequence
specific assignment of backbone protons were carried out for all
the peptides and vicinal coupling constants and temperature
coefficients of chemical shifts for amide NH resonance were
determined. The results are summarized in Table 2.
Fig. 3 summarizes the key NOEs observed between the back-
bone protons in peptide 3 (DVal(5)) and 4 (LVal(5)). In the case
of peptide 3 the observation of the NOEs Val(2)CαH ↔ Val(7)
CαH, Val(3)NH ↔ Leu(6)NH and Leu(1)NH ↔ Val(8)NH are
diagnostic of a significant population of β-hairpin conformations
in solution. The absence of these sequential NOEs, Val(2)NH ↔
Val(3)NH and Val(3)NH ↔ Ac6c(4)NH is also suggestive of the
fact that helical conformations at the N-terminus are not
Fig. 1 Aib-DAla (a) and Aib-DPro (b) segments adopting type I′ β-turn conformation octapeptide β-hairpins.5,6 (c) Aib-DVal segment forming a
right-handed helical turn (type I β-turn) in a synthetic 19 residue designed peptide.7 Aib-DXxx segments are shown as ball and stick.
Fig. 2 Low field proton resonance (amide NH aromatic protons) in
peptides 1–4. Residue specific assignment are indicated for NH
resonances.
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populated significantly in solution. In contrast, peptide 4 reveals
a complete set of sequential NiH ↔ Ni+1H NOEs over the entire
length of the sequence. Furthermore the diagnostic hairpin
NOEs Leu(1)NH ↔ Val(8)NH and Val(2)CαH ↔ Val(7)CαH are
also absent. These observations suggest that peptide 3 (DVal(5))
favors β-hairpin conformations in solution, whereas the corre-
sponding LVal analog (peptide 4) adopts a continuous helical
conformation. Similar results were obtained for peptides 1 and 2,
which contain aromatic residues in the strands at positions 2 and
7. Here again diagnostic hairpin NOEs are observed for (DVal
(5)) peptide 1 while peptide 2 (LVal(5)) reveals only NOEs
characteristic of a helical conformation (Fig. S1, ESI†).
In the case of ideal β-hairpin conformations, Val(3), Leu(6),
Val(8) and Leu(1)NH and CO groups are internally hydrogen
bonded. In earlier studies of β-hairpins it has frequently been
observed that the Leu(1)NH⋯Val(8)CO hydrogen bond, which
bridges the N and C termini of hairpins, is often frayed.12 In a
310-helical structure the NH groups of residues 3 to 8 are
expected to be involved in intramolecular 4 → 1(310) hydrogen
bonds, while in an α-helical conformation Val(3)NH may be
more solvent exposed. Inspection of the temperature coefficients
of chemical shifts (dδ/dT) in methanol provides some useful cor-
relations. The measured dδ/dT values are spread over the range
−2.1 to −9.1 ppb K−1. The NH group of residue 2, which is
anticipated to be solvent exposed in both helical and hairpin
structures, has a dδ/dT value > 6 ppb K−1 in all four peptides.
The Leu(1)NH group shows significantly lower dδ/dT values
(−2.1 ppb K−1 and −5.6 ppb K−1) in peptides 1 and 3 (DVal(5))
as compared to peptides 2 and 4 (LVal(5)) (−7.6 ppb K−1 and
−8.1 ppb K−1). In hairpin structures, where all four possible
Fig. 3 Partial ROESY spectra of peptides 3 (right) and 4 (left). (a) Cα proton region, (b) NH–CαH region, (c) NH–NH region. NOEs characteristic of
hairpins (dαα 2/7 and dNN 3/6) are boxed.
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cross-strand hydrogen bonds occur, Leu(1)NH is involved in an
interaction with the Val(8)CO group. This hydrogen bond is
often disturbed in crystal structures, with Val(8)CO participated
in intermolecular interactions. Such fraying is a common feature
and is also likely to occur in solution in hydrogen bonding sol-
vents like methanol, which can compete for potential backbone
hydrogen bonding sites. The Ac6c NH (residue 4) might be
expected to form an internal hydrogen bond in helical structures,
while remaining solvent exposed in the β-hairpin. Indeed, the
observed dδ/dT values for peptides 1 and 3 (−6.4 ppb K−1 and
−6.1 ppb K−1) are significantly higher than those observed in
peptides 2 and 4 (−4.5 ppb K−1 and −3.7 ppb K−1). Leu(6)NH
exhibits a relatively low dδ/dT value in all four peptides (−2.2
ppb K−1 to −4.3 ppb K−1) consistent with its involvement in an
internal hydrogen bond, in both potential hairpin and helical
structures. Residue 7NH shows a dramatic difference in dδ/dT
values in peptides 1 and 3 (−7.9 ppb K−1 and −8.4 ppb K−1) as
compared to peptides 2 and 4 (−3.7 ppb K−1 and −3.5 ppb
K−1). In hairpins, residue 7NH is solvent exposed, while in
helices solvent shielding is anticipated. Val(8)NH shows a rela-
tively high dδ/dT values in all four peptides (−5.5 ppb K−1 to
−7.8 ppb K−1). This C-terminus residue is solvent exposed in
the octapeptide hairpins, while the C-terminus NH group in
short peptide helices is more prone to solvation, resulting in a
higher value of the temperature co-efficient. Residue 5NH is
expected to be internally hydrogen bonded in helical structures
and exhibits moderately low dδ/dT values (−3.1 ppb K−1 and
−5.7 ppb K−1), in both peptides 2 and 4. In the octapeptide
hairpin, residue 5NH is a part of the central peptide unit of the
nucleating β-turn and does not participate in an internal hydro-
gen bond. The relatively low dδ/dT value of −3.1 ppb K−1 and
−3.7 ppb K−1 for residue 5NH is a consequence of steric and
electrostatic shielding anticipated in a Type I′ turn, which places
the NH group proximate to the Val(3)CO group (N⋯O ≈ 3.09Å)
in peptides 1 and 3. The observed dδ/dT value for Val(3)NH are
anomalously, high in peptides 1 and 3, since this NH is expected
to be internally hydrogen bonded in the hairpin conformation.
Interestingly, Val(3)NH appears at the lowest field position of all
NH resonances in β-hairpin peptides containing Leu-Phe-Val/
Leu-Val-Val strand segments studied so far. Clearly, factors other
than internal hydrogen bonding contribute predominantly to the
chemical shift and also its temperature dependence. Interestingly,
two distinct side chain conformations have been characterized in
crystals for the peptide β-hairpin Boc-Leu-Phe-Val-DPro-Ala-
Leu-Phe-Val-OMe (unpublished results). In one of these confor-
mation the aromatic side chain Phe(2) lies proximate to the Val
(3)NH group. The changes in Phe side chain conformation with
temperature may contribute significantly to the observed chemi-
cal shift of Val(3). Interpretation of temperature co-efficients are
often rendered ambiguous because of the difficulties of assigning
contributions from competing process like solvation and local
conformational changes. Exchange with solvent (CH3OH)
protons at higher temperature also results in broadening of
solvent exposed NH resonances. A further point of interest is
that the vicinal coupling constant, 3JNHC
α
H, values for residues
2, 3 and 6 are significantly greater in peptides 1 and 3 (Xxx =
DVal(5)) as compared to peptides 2 and 4 (5.2 to 7.7 Hz, Xxx =
LVal(5)).
The NMR results thus suggest that the placement of a D-
residue at position 5 (peptides 1 and 3), following an achiral
β-turn promoting residue, Ac6c, results in enhancing the
propensity of β-hairpin formation in methanol solution. Solution
structures were computed for Boc-Leu-Phe-Val-Ac6c-
DVal-Leu-
Phe-Val-OMe (peptide 1) and Boc-Leu-Val-Val-Ac6c-
DVal-Leu-
Val-Val-OMe (peptide 3) from observed ROESY data. 19 NOEs
restraints were used in a simulated annealated protocol resulting
in an ensemble of 100 structures. Fig. 4 shows a superposition
of 10 β-hairpin structures with an RMSD 0.39 Å for peptide 1.
A single representative conformer illustrating the Ac6c-
DVal
hairpin forming turn is also shown. Similar results were also
obtained for peptide 3 using measured NOE restraints.
In the case of an L-residue at position 5 (peptides 2 and 4) the
NMR data are consistent with a preponderance of continuous
helical conformations. In these cases the helical conformations
were established by crystal structure determination as described
below.
X-ray diffraction
Fig. 5 shows the molecular conformation of peptides 2 and 4 in
crystals. The stereo-view of the molecular conformation is
shown in Fig. S2 and S3, ESI.† Peptide 2 crystallized from
methanol–water mixture in the orthorhombic space group
P212121, with one molecule in the asymmetric unit. Peptide 4
crystallized from an isopropanol–water mixture in the monocli-
nic space group P21, with two peptide molecules and one water
molecule in the asymmetric unit. Table 1 summarizes the crystal
and diffraction parameters for peptides 2 and 4. The backbone
and side chain torsion angles and the hydrogen bond parameters
are summarized in Tables 3 and 4, respectively.
Boc-Leu-Phe-Val-Ac6c-Val-Leu-Phe-Val-OMe (2). Inspection
of ϕ and ψ values from Table 3 reveals that residues 1 to 5 adopt
right handed helical conformations and Leu(6) falls in the bridge
region of the Ramachandran map. Residues 7 and 8 adopt non-
helical values. Val(8) lies in the bridge region. The hydrogen
bond pattern reveals that the molecule is stabilized by mixed
4 → 1/5 → 1 hydrogen bonds (three 4 → 1 and three 5 → 1).
Fig. 4 (Left): Superposition of 10 NMR derived backbone confor-
mations for Boc-Leu-Phe-Val-Ac6c-
DVal-Leu-Phe-Val-OMe (RMSD =
0.39 Å). (Right): One representative hairpin conformation. The Ac6c
residue is shown.
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The simultaneous formation of two hydrogen bonds by a single
acceptor CO is observed at the N and C termini. The molecular
conformation can be described as a mixed α/310 helix, based on
the hydrogen bond pattern. Molecules are packed in crystals as
columns of helices, stabilized by two head-to-tail hydrogen
bonds. In addition to the head-to-tail hydrogen bonds, aromatic–
aromatic interactions between the Phe residues may also contrib-
ute (Fig. S4, ESI†). The columns of helices run antiparallel to
each other. When viewed down the helix axis, the molecules are
arranged in a pseudo-hexagonal grid arrangement13 (Fig. S5,
ESI†). The carbonyl oxygen of Val(2), Val(5) and Val(8) are not
involved in hydrogen bond formation.
Fig. 5 Top: (a) Molecular conformation of Boc-Leu-Phe-Val-Ac6c-
LVal-Leu-Phe-Val-OMe (2) in crystals. (b) The asymmetric unit of peptide Boc-
Leu-Val-Val-Ac6c-
LVal-Leu-Val-Val-OMe (4) in crystals. Bottom: The backbone of peptides 2 and 4 with only Ac6c residue shown. The hydrogen
bonds are shown as dotted lines.
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Boc-Leu-Val-Val-Ac6c-Val-Leu-Val-Val-OMe (4). Inspection
of ϕ, ψ values from Table 3 reveals that residues 1 to 5 adopt
right handed helical conformations and Leu(6) falls in the bridge
region, in both the molecules A and B. Residues 7 and 8 adopt
non-helical values. In molecule AVal(8) lies in the bridge region
and in the extended region in molecule B. The hydrogen bond
pattern reveals that the molecule is stabilized by mixed 4 → 1/5
→ 1 hydrogen bonds (three 4 → 1 and three 5 → 1). Acceptors
at the N and C termini form two simultaneous interactions with
the donor NH groups. The molecular conformation can be
described as a mixed α/310 helix, based on the hydrogen bond
pattern. In molecule B, there are additional hydrogen bonds
observed between water (O1w) and Val(5)CO and Val(8)CO. An
interesting feature in the present crystal structure is the coexis-
tence of solvated and unsolvated molecules in the asymmetric
unit. The molecules are arranged antiparallel to each other (inter-
helical angle ∼ 176.5°) and packed as column of helices stabil-
ized by two head-to-tail hydrogen bonds. The columns of
helices run antiparallel in pairs in the crystal lattice. When
viewed down the helix axis, the molecules are arranged in a
square grid arrangement (Fig. S6, ESI†). In molecule A, the car-
bonyl oxygen atoms of Val(2), Val(5) and Val(8) are not involved
in any hydrogen bond formation and in molecule B the carbonyl
Table 1 Crystal and diffraction parameter for peptides 2 and 4
Peptide 2 Peptide 4
Empirical formula C58 H90 N8 O11 C50 H90 N8 O11·0.5H2O
Crystal habit Transparent Transparent, needle like
Crystal size (mm) 0.8 × 0.3 × 0.2 0.5 × 0.15 × 0.15
Crystallizing solvent Methanol–water Isopropanol–water
Space group P212121 P21
Cell parameters
a (Å) 11.312(4) 10.516(3)
b (Å) 19.868(6) 27.593(4)
c (Å) 28.099(9) 21.050(3)
α (°) 90 90
β (°) 90 97.919(3)
γ (°) 90 90
Volume (Å3) 6315(3) 6050(2)
Z 4 4
Molecules/asym.unit 1 2
Cocrystallized solvent None One water molecule
Molecular weight 1075.38 978.3 + 9 = 987.3
Density (g cm−3)
(cal)
1.131 1.084
F (000) 2328 2152
Radiation MoKα (λ = 0.71073 Å) MoKα (λ = 0.71073 Å)
Temperature (°C) 21 21
2θ max (°) 53.8 56.1
Scan type ω ω
Measured reflections 62 458 71 594
Independent
reflections
12 729 28 276
Unique reflections 7153 14 733
Observed
reflections
[|F| > 4σ(F)]
4488 8010
Final R(%) 7.67 6.44
Final wR2(%) 16.19 15.73
Goodness-of-fit (S) 1.075 0.98
Δρmax (e Å
−3) 0.39 0.63
Δρmin (e Å
−3) −0.24 −0.24
No. of restraints/
parameters
0/694 3/1252
Data-to-parameter
ratio
6.5 : 1 6.4 : 1
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oxygen of Val(2) is not involved in hydrogen bond formation.
In both peptides 2 and 4 the amino group of Ac6c is in an axial
position on the cyclohexane ring. The molecular conformations
established for peptide 2 and 4 in crystals are in agreement with
the helical conformations deduced from NMR data in the pre-
vious section. Repeated attempts to obtain crystals of peptides 1
and 3 over several years were unsuccessful.
Conclusion
The incorporation of sterically constrained α,α-dialkylated resi-
dues at central positions in short sequences containing L-amino
acids induces right-handed helix formation. Several crystal struc-
tures are now available for short sequences containing a single
α,α-dialkylated residue, in which helical folds, closely related to
right-handed 310/α-helical structures, have been characterized.
1,2
Helix nucleation may be favored by the tendency of the central
segment containing α,α-dialkylated residue to form type I/III
β-turn conformations.2e The present study was designed in order
to explore the effect of changing the conformation of the chiral
residue that immediately follows the stereochemically con-
strained residue. This comparative study of octapeptides contain-
ing centrally positioned Ac6c-
LVal and Ac6c-
DVal segments
reveals that helices are predominately populated in solution in
the former, while β-hairpins predominate in the latter. Secondary
structure nucleation by designed segments with limited confor-
mational choices can prove effective in the design of short pep-
tides adopting well defined conformations. In many previous
studies of peptide β-hairpins the D-proline residue has been used
to promote formation of type II′ β-turns as a means of hairpin
nucleation.3,14 The present study provides further support for the
design principle that type I′ turns constructed using α,α-dialky-
lated residues are also effective in hairpin nucleation.5,6
Experimental section
Peptide synthesis
The peptides were synthesized by standard solution-phase pro-
cedures. The tert-butoxycarbonyl (Boc) group was used for N-
terminus protection, and the C-terminus was protected as a
methyl ester. Deprotections were performed using 98% formic
acid for the Boc group and saponification for the methyl ester.
The final step in the synthesis of peptides was achieved by the
fragment condensation of Boc-Leu-Val-Val-OH/Boc-Leu-Phe-
Val-OH with H2N-Ac6c-X-Leu-Val-Val-OMe/H2N-Ac6c-X-Leu-
Phe-Val-OMe (X = L-Val or D-Val), using N,N′-dicyclohexylcar-
bodiimide (DCC)–1-hydroxybenzotriazole (HOBt) as the
coupling reagent. All the intermediates were characterized by
electrospray ionization mass spectrometry (ESI-MS) on a Bruker
Daltonics Esquire-3000 instrument and thin-layer chromato-
graphy (TLC) on silica gel and used without further purification
for the final step. The target peptides were purified by reverse-
phase medium-pressure liquid chromatography (RP-MPLC, C18,
40–60 μm) and high-performance liquid chromatography
(HPLC) on a reverse-phase C18 column (5–10 μm, 7.8 mm ×
250 mm) using methanol–water gradients. The purified peptides
were characterized by ESI-MS. Mass spectral data (m/z): pep-
tides 1 and 2, 1074.2 [M + H]+ (Mcal) 1073.4 Da, 1097.1 [M +
Na]+, 1113.2 [M + K]+; 3 and 4, 978.1 [M + H]+ (Mcal) 977.4
Da, 1001.2 [M + Na]+, 1017.4 [M + K]+.
NMR spectroscopy
Experiments were carried out on Bruker AV700 and DRX500
spectrometers. 1D and 2D spectra were recorded at a peptide
concentration of ∼5 mM in CD3OH at 300 K. Resonance
Table 3 Torsion angles for peptides 2 and 4 (°)a
Residue
Peptide 2 (Xxx = Phe) Peptide 4 (Xxx = Val)
Molecule-A Molecule-B
ϕ ψ ω ϕ ψ ω ϕ ψ ω
Leu(1) −60.0b −29.2 178.5 −45.9b −45.6 −175.8 −51.3e −41.1 −177.2
Xxx(2) −59.7 −30.2 174.5 −58.1 −40.4 174.7 −59.2 −38.7 175.3
Val(3) −87.9 −42.4 −176.7 −70.1 −47.6 −174.3 −69.9 −45.7 −175.4
Ac6c(4) −51.4 −41.2 −174.1 −50.0 −48.4 −171.1 −51.7 −47.7 −172.8
Val(5) −70.4 −10.4 173.2 −74.8 −12.2 172.5 −75.0 −11.2 172.9
Leu(6) −82.9 −12.2 −176.1 −91.2 −4.7 −179.6 −93.2 0.5 −178.3
Xxx(7) −110.1 −47.4 −176.5 −108.7 −46.2 −177.6 −113.7 −52.9 −174.4
Val(8) −124.6 −16.9c −178.7d −119.3 −11.5c 177.6d −96.7 154.0f 178.6g
Side chain χ1 χ2 χ1 χ2 χ1 χ2
Leu(1) −74.4 −76.3, 155.1 −175.0 76.0, −163.8 −178.8 −92.6, 153.9
Xxx(2) −79.3 22.2, −158.1 −68.0, 167.4 −68.7, 172.6
Val(3) −61.8, 175.0 −61.1, 174.3 −62.5, 173.0
Val(5) −68.5, 69.0 −61.3, 65.9 −60.7, 68.5
Leu(6) −54.5 −54.6, 177.3 −67.3 −69.1, 168.0 −70.0 −69.8, 167.5
Xxx(7) −69.9 79.2, −98.8 −60.2, 176.9 −61.2, 175.2
Val(8) −67.6, 60.1 −64.1, 60.3 −64.2, 61.8
a The torsion angles for rotation about bonds of the peptide backbone (ϕ, ψ and ω) and about bonds of the amino acid side chains (χ1, χ2) as suggested
by the IUPAC-IUB Commission on Biochemical Nomenclature. Biochemistry 1970, 9, 3471–3479. The standard deviation in torsion angles are 0.3°
and 0.2° for peptides 2 and 4 respectively. bC′(0)–N(1)–Cα(1)–C′(1). cN(8)–Cα(8)–C′(8)–O1(OMe). dCα(8)–C′(8)–O1(OMe)–C1(OMe). eC′(10)–N
(11)–Cα(11)–C′(11). fN(18)–Cα(18)–C′(18)–O2(OMe). gCα(18)–C′(18)–O2(OMe)–C2(OMe).
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assignments were carried out with the help of 1D and 2D
spectra. Residue specific assignments were obtained from
TOCSY experiments, whereas ROESY spectra permitted
sequence specific assignments. The TPPI (time proportional
phase incrementation) method was used for phase sensitive 2D
experiments. A data set of 1024 × 450 was used for acquiring
the data. The same data set was zero filled to yield a data matrix
of size 2048 × 1024, before Fourier transformation. A spectral
width of 6000 and 8700 Hz was used in both dimensions at 500
and 700 MHz, respectively. Mixing times of 100 and 200 ms
were used for TOCSY and ROESY, respectively. Shifted square
sine bell windows were used and all processing was done using
BRUKER TOPSPIN software.
Structure calculations
Solution structures were computed using the Discover module
(version 2000) of InsightII (Accelyrs, San Diego, CA) from
ROESY cross-peaks. The NOE restraints were categorized into
three groups: strong (2.5 Å upper limit), medium (3.5 Å upper
limit), and weak (5.0 Å upper limit). These distances were
employed using generic distance restraints with force constants
of 1 kcal mol−1 Å2
−1 and a maximum force value of 1000 kcal
mol−1 Å2
−1. The consistent valence force field (CVFF) was
applied for all calculations. Prior to every restrained dynamics
simulation the system was equilibrated for 1 ps. The energy
minimized structures were subjected to constrained MD simu-
lations for a duration of 2 ns (8 cycles each of 2.5 ps period, of
the Simulated Annealing Protocol). After simulating for 2.5 ps at
high temperature, the system temperature was reduced exponen-
tially over a 2.5 ps period to reach a final temperature of 300 K.
At regular intervals, 100 conformers were extracted, leading to
an ensemble of 100 structures and subjected to energy minimiz-
ation by conjugate gradient method. The resulting structures
were analyzed with Pymol and InsightII. A total of 19 NOE
restraints were used for both peptides 1 and 3.
Table 4 Hydrogen bonds in peptides 2 and 4
Type Donor Acceptor N⋯O/O⋯O (Å) H⋯O (Å) CvO⋯H (°) CvO⋯N (°) O⋯H–N (°)
Peptide 2
Intermolecular
N(1) O(6)a 2.870 2.055 130.4 134.7 157.8
N(2) O(7)a 3.168 2.336 137.7 141.8 163.0
Intramolecular
4→ 1 N(3) O(0) 2.923 2.199 121.9 129.8 141.7
5→ 1 N(4) O(0) 3.074 2.237 144.7 149.1 164.2
5→ 1 N(5) O(1) 3.132 2.306 149.8 151.4 161.2
4→ 1 N(6) O(3) 2.899 2.100 119.6 126.9 154.2
4→ 1 N(7) O(4) 2.985 2.162 117.7 122.9 160.1
5→ 1 N(8) O(4) 3.120 2.265 169.5 171.3 172.5
Peptide 4
Molecule-A
Intermolecular
N(11) O(16)b 2.908 2.093 126.6 130.7 158.0
N(12) O(17)b 3.024 2.167 151.8 153.0 173.8
Intramolecular
4→ 1 N(13) O(10) 2.914 2.343 125.8 136.3 124.2
5→ 1 N(14) O(10) 3.032 2.184 149.0 152.1 168.4
5→ 1 N(15) O(11) 3.047 2.210 159.5 160.4 164.2
4→ 1 N(16) O(13) 2.899 2.100 119.6 126.9 154.2
4→ 1 N(17) O(14) 2.985 2.162 117.7 122.9 160.1
5→ 1 N(18) O(14) 3.006 2.150 169.3 170.4 173.3
Molecule-B
Intermolecular
N(21) O(26)c 2.869 2.065 124.0 129.2 155.5
N(22) O(27)c 3.103 2.251 147.1 149.0 171.1
Solvent O1w O(25) 2.756
Solvent O1w O(28) 3.222
Intramolecular
4→ 1 N(23) O(20) 2.926 2.343 123.5 133.7 125.4
5→ 1 N(24) O(20) 3.074 2.237 144.7 149.1 164.2
5→ 1 N(25) O(21) 3.132 2.306 149.8 151.4 161.2
4→ 1 N(26) O(23) 2.992 2.267 111.3 121.2 142.1
4→ 1 N(27) O(24) 3.057 2.241 112.1 116.1 158.4
5→ 1 N(28) O(24) 3.111 2.254 173.6 172.2 174.2
a Symmetry related by −x+3/2, −y, z − 1/2. b Symmetry related by −x+1, y−1/2, −z + 1. c Symmetry related by −x + 1, y + 1/2, −z. The standard
deviation in bond lengths and bond angles are 0.004 Å and 0.3° and 0.002 Å and 0.2° for peptides 2 and 4 respectively.
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X-ray diffraction
Single crystals of peptides 2 and 4 were grown from methanol–
water and isopropanol–water solutions, respectively. Despite
repeated trials, suitable crystals of peptides 1 and 3 could not be
obtained. Table 1 summarizes the crystallographic data and other
details for the compounds 2 and 4. X-ray diffraction data were
collected on a Bruker AXS SMART APEX CCD diffractometer
using MoKα radiation (λ = 0.71073 Å). The structures were
solved by direct methods using SHELXD.15 For peptide 2, a
fragment containing 69 atoms was obtained. For peptide 4 two
fragments were obtained containing 59 and 47 atoms. The
remaining atoms and solvent molecules were located from differ-
ence Fourier-maps. Full matrix least squares refinement was
carried out using SHELXL-97.15 The hydrogen atoms were
fixed geometrically in idealized positions and refined in the final
cycle of refinement, as riding over the atoms to which they are
bonded. The final R-factor was 7.67% for peptide 3 and 6.44%
for peptide 4. The crystallographic coordinates for the structures
are deposited at the Cambridge Crystallographic Data Centre
with CCDC numbers 850190 (2) and 850189 (4).
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